Oscar Health, Inc.
OSCRHealthcareNASDAQHealthcare Plans · Last scanned Oct 26, 2026
Scan Results
Daily timeframeOscar Health, Inc. operates as a healthcare technology company in the United States. The company carries a $9.56B market cap, placing it firmly in the mid-cap category. The company offers health plans to individuals, families, employees, and small group markets.
Market Cap
$9.56B
Beta
2.47
P/E (TTM)
24.02
P/E (Fwd)
13.95
EPS (TTM)
$1.29
EPS (Fwd)
$2.22
ROE
34.3%
ROA
4.5%
Cash
$8.56B
Total Debt
$482.1M
Free CF
$692.5M
52W Change
57.6%
Annual Financials
Cash vs Debt
Where OSCR stands vs its 150-day and 200-day moving averages
As of the October 15, 2026 close, OSCR finished 35.38% above its 150-day moving average ($25.35) and 51.46% above its 200-day moving average ($22.66). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is OSCR overbought or oversold?
At the October 15, 2026 close, OSCR's RSI(14) was 84.4, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $8.56B in cash comfortably exceeding the $482.1M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. The company generates $692.5M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 34.3% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.5% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $4.13B (2022) to $11.70B (2025), reflecting a 184% increase over the period.
Oscar Health, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing OSCR.